The Relationship Between Well-being and HbA1c in Adults with Type 1 Diabetes: A Systematic Review

Overview

Journal J Diabetes

Specialty Endocrinology

Date 2023 Feb 16

PMID 36796311

Authors

Aida Perez-Fernandez

Pablo Fernandez-Berrocal

Maria Jose Gutierrez-Cobo

Affiliations

Soon will be listed here.

Abstract

Background: Diabetes has been associated with psychological problems, which in turn have been related to poorer glycemic control (glycosylated hemoglobin [HbA1c]). On the contrary, psychological well-being constructs have been associated with superior medical outcomes, including better HbA1c.

Aim: The main objective of this study was to systematically review the existing literature about the relationships between subjective well-being (SWB) and HbA1c in adults with type 1 diabetes (T1D).

Methods: Comprehensive searches were conducted in PubMed, Scopus, and Medline, time restricted to 2021, for studies examining the link between HbA1c and the cognitive (CWB) and affective (AWB) components of SWB. A total of 16 eligible studies were selected according to the inclusion criteria, of which 15 measured CWB and 1 AWB.

Results: Of the 15 studies included, 11 showed a relationship between CWB and HbA1c, with a higher level of HbA1c being related to poorer CWB. The other four studies did not find any significant association. Finally, the only study examining the relationship between AWB and HbA1c found a marginally association between these variables in the expected direction.

Conclusion: The overall data suggest that CWB is negatively related to HbA1c in this population, but these results are inconclusive. This systematic review offers clinical implications, such as the possible evaluation, prevention, and treatment of the problems associated with diabetes through the study and training of the psychosocial variables that may directly influence SWB. Limitations and future lines of investigation are discussed.

Citing Articles

Short-Term Impact of Digital Mental Health Interventions on Psychological Well-Being and Blood Sugar Control in Type 2 Diabetes Patients in Riyadh.

Alodhialah A, Almutairi A, Almutairi M Healthcare (Basel). 2024; 12(22).

PMID: 39595455 PMC: 11593722. DOI: 10.3390/healthcare12222257.

Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetes.

Nattero-Chavez L, de La Calle E, Lecumberri-Pascual E, Bayona Cebada A, Ruiz Gracia T, Quintero Tobar A Ther Adv Endocrinol Metab. 2024; 15:20420188241288789.

PMID: 39493410 PMC: 11528595. DOI: 10.1177/20420188241288789.

Discordance between mean glucose and time in range in relation to HbA in individuals with type 1 diabetes: results from the GOLD and SILVER trials.

Sterner Isaksson S, Imberg H, Hirsch I, Schwarcz E, Hellman J, Wijkman M Diabetologia. 2024; 67(8):1517-1526.

PMID: 38668761 PMC: 11343832. DOI: 10.1007/s00125-024-06151-2.

Depression, anxiety, and health-related quality of life in normal weight, overweight and obese individuals with diabetes: a representative study in Germany.

Herhaus B, Kruse J, Hinz A, Brahler E, Petrowski K Acta Diabetol. 2024; 61(6):725-734.

PMID: 38430257 PMC: 11101582. DOI: 10.1007/s00592-024-02248-7.

Sociodemographic and Clinical Determinants on Health-Related Quality of Life in Emerging Andalusian Adults with Type 1 Diabetes: A Cross-Sectional Study.

Nunez-Baila M, Gomez-Aragon A, Gonzalez-Lopez J J Clin Med. 2024; 13(1).

PMID: 38202247 PMC: 10779847. DOI: 10.3390/jcm13010240.

References

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H, Kruger J . The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes. Med Decis Making. 2016; 36(8):1020-33. PMC: 5046160. DOI: 10.1177/0272989X16658660. View

Thomakos P, Panagopoulos G, Kepaptsoglou O, Zoupas C, Mitrakou A . WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?. Georgian Med News. 2018; (277):61-67. View

Buchberger B, Huppertz H, Krabbe L, Lux B, Mattivi J, Siafarikas A . Symptoms of depression and anxiety in youth with type 1 diabetes: A systematic review and meta-analysis. Psychoneuroendocrinology. 2016; 70:70-84. DOI: 10.1016/j.psyneuen.2016.04.019. View

. Standards of medical care in diabetes--2014. Diabetes Care. 2013; 37 Suppl 1:S14-80. DOI: 10.2337/dc14-S014. View

. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care. 1988; 11(9):725-32. DOI: 10.2337/diacare.11.9.725. View

DuBois C, Beach S, Kashdan T, Nyer M, Park E, Celano C . Positive psychological attributes and cardiac outcomes: associations, mechanisms, and interventions. Psychosomatics. 2012; 53(4):303-18. DOI: 10.1016/j.psym.2012.04.004. View

Schram M, Baan C, Pouwer F . Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev. 2009; 5(2):112-9. PMC: 2764861. DOI: 10.2174/157339909788166828. View

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

10.

Forga L . [The epidemiology of type 1 diabetes: helping to fit the puzzle pieces]. Endocrinol Nutr. 2015; 62(4):149-51. DOI: 10.1016/j.endonu.2015.02.002. View

11.

Ryff C, Love G, Urry H, Muller D, Rosenkranz M, Friedman E . Psychological well-being and ill-being: do they have distinct or mirrored biological correlates?. Psychother Psychosom. 2006; 75(2):85-95. DOI: 10.1159/000090892. View

12.

Alvarado-Martel D, Velasco R, Sanchez-Hernandez R, Carrillo A, Javier Novoa F, Maria Wagner A . Quality of life and type 1 diabetes: a study assessing patients' perceptions and self-management needs. Patient Prefer Adherence. 2015; 9:1315-23. PMC: 4576890. DOI: 10.2147/PPA.S87310. View

13.

Ingerski L, Laffel L, Drotar D, Repaske D, Hood K . Correlates of glycemic control and quality of life outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2010; 11(8):563-71. DOI: 10.1111/j.1399-5448.2010.00645.x. View

14.

Smith K, Beland M, Clyde M, Gariepy G, Page V, Badawi G . Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013; 74(2):89-99. DOI: 10.1016/j.jpsychores.2012.11.013. View

15.

Weinger K, Jacobson A . Psychosocial and quality of life correlates of glycemic control during intensive treatment of type 1 diabetes. Patient Educ Couns. 2000; 42(2):123-31. DOI: 10.1016/s0738-3991(00)00098-7. View

16.

Busseri M, Sadava S . A review of the tripartite structure of subjective well-being: implications for conceptualization, operationalization, analysis, and synthesis. Pers Soc Psychol Rev. 2010; 15(3):290-314. DOI: 10.1177/1088868310391271. View

17.

Mortensen H, Robertson K, Aanstoot H, Danne T, Holl R, Hougaard P . Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes. Diabet Med. 1998; 15(9):752-9. DOI: 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W. View

18.

Dluzniak-Golaska K, Szostak-Wegierek D, Panczyk M, Szypowska A, Sinska B . May gender influence the quality of life in children and adolescents with type 1 diabetes?. Patient Prefer Adherence. 2019; 13:1589-1597. PMC: 6759230. DOI: 10.2147/PPA.S206969. View

19.

Reddy M, Godsland I, Barnard K, Herrero P, Georgiou P, Thomson H . Glycemic Variability and Its Impact on Quality of Life in Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2015; 10(1):60-6. PMC: 4738216. DOI: 10.1177/1932296815601440. View

20.

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View